In Type 1 diabetes mellitus the body does not produce enough insulin, which is required to convert sugar and other food into energy for the body. The disease is typically diagnosed in children and young adults and requires lifelong insulin therapy. This study is looking at administering oral insulin to patients with risk factors for developing diabetes to see if it will prevent or delay the development of the disease.
Medication Under Study:
Full study title:
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus (TN-07) Protocol TN-07
IRB Study ID:
Who may qualify:
Patients with risks factors for developing type 1 diabetes mellitus
Who does not qualify:
Patients already taking medications that may affect glucose, have certain medical conditions or are not at risk for developing diabetes
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-5012
What to expect when coming to Akron Children's
For healthcare providers and nurses
Residency & Fellowships, Medical Students, Nursing and Allied Health
For prospective employees and career-seekers
Our online community that provides inspirational stories and helpful information.